Dendritic cell anti-tumor vaccine(LDG Labor)

树突细胞抗肿瘤疫苗（LDG Labor）

Report date: 2022/08/25 18:07:03

Base Information

Drug NameDendritic cell anti-tumor vaccine(LDG Labor)

Drug Alias NameLANEX-DC

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermanyMacau

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesGD Unlon Biotechnology Medicine Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesGD Unlon Biotechnology Medicine Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A